Multi-omics Analysis of Ferroptosis Regulation Patterns and Characterization of Tumor Microenvironment in Patients with Oral Squamous Cell Carcinoma

被引:31
作者
Gu, Wenchao [1 ]
Kim, Mai [2 ]
Wang, Lei [3 ,4 ]
Yang, Zongcheng [5 ,6 ,7 ]
Nakajima, Takahito [8 ]
Tsushima, Yoshito [1 ]
机构
[1] Gunma Univ, Dept Diagnost Radiol & Nucl Med, Grad Sch Med, Maebashi, Gumma, Japan
[2] Gunma Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg & Plast Surg, Maebashi, Gumma, Japan
[3] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[5] Shandong Univ, Cheeloo Coll Med, Sch & Hosp Stomatol, Dept Implantol, Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[6] Shandong Key Lab Oral Tissue Regenerat, Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[7] Shandong Engn Lab Dent Mat & Oral Tissue Regenera, Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[8] Univ Tsukuba, Dept Diagnost & Intervent Radiol, Ibaraki, Japan
关键词
Ferroptosis; Oral squamous cell carcinoma; Prognosis; Tumor microenvironment; Immunotherapy; CANCER; EXPRESSION; FEATURES; PREDICTION; SIGNATURE; SURVIVAL; DEATH;
D O I
10.7150/ijbs.61441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is a newly recognized mechanism of regulated cell death. It was reported to be highly associated with immune therapy and chemotherapy. However, its mechanism of regulation in the tumor microenvironment (TME) and influence on oral squamous cell carcinoma (OSCC) therapy are unknown. We identified a ferroptosis-specific gene-expression signature, an FPscore, developed by a principal component analysis (PCA) algorithm to evaluate the ferroptosis regulation patterns of individual tumor. Multi-omics analysis of ferroptosis regulation patterns was conducted. Three distinct ferroptosis regulation subtypes, which linked to outcomes and the clinical relevance of each patient, were established. A high FPscore of patients with OSCC was associated with a favorable prognosis, a ferroptosis-related immune-activation phenotype, potential sensitivities to the chemotherapy and immunotherapy. Importantly, a high FPscore correlated with a low gene copy number burden and high immune checkpoint expressions. We validated the prognostic value of the FPscore using independent immunotherapy and pan-cancer cohorts. Comprehensive evaluation of individual tumors with distinct ferroptosis regulation patterns provides new mechanistic insights, which may be clinically relevant for the application of combination therapies in OSCC.
引用
收藏
页码:3476 / 3492
页数:17
相关论文
共 57 条
[1]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[2]   Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice [J].
Angeli, Jose Pedro Friedmann ;
Schneider, Manuela ;
Proneth, Bettina ;
Tyurina, Yulia Y. ;
Tyurin, Vladimir A. ;
Hammond, Victoria J. ;
Herbach, Nadja ;
Aichler, Michaela ;
Walch, Axel ;
Eggenhofer, Elke ;
Basavarajappa, Devaraj ;
Radmark, Olof ;
Kobayashi, Sho ;
Seibt, Tobias ;
Beck, Heike ;
Neff, Frauke ;
Esposito, Irene ;
Wanke, Ruediger ;
Foerster, Heidi ;
Yefremova, Olena ;
Heinrichmeyer, Marc ;
Bornkamm, Georg W. ;
Geissler, Edward K. ;
Thomas, Stephen B. ;
Stockwell, Brent R. ;
O'Donnell, Valerie B. ;
Kagan, Valerian E. ;
Schick, Joel A. ;
Conrad, Marcus .
NATURE CELL BIOLOGY, 2014, 16 (12) :1180-U120
[3]   Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].
Balar, Arjun V. ;
Galsky, Matthew D. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Loriot, Yohann ;
Necchi, Andrea ;
Hoffman-Censits, Jean ;
Perez-Gracia, Jose Luis ;
Dawson, Nancy A. ;
van der Heijden, Michiel S. ;
Dreicer, Robert ;
Srinivas, Sandy ;
Retz, Margitta M. ;
Joseph, Richard W. ;
Drakaki, Alexandra ;
Vaishampayan, Ulka N. ;
Sridhar, Srikala S. ;
Quinn, David I. ;
Duran, Ignacio ;
Shaffer, David R. ;
Eigl, Bernhard J. ;
Grivas, Petros D. ;
Yu, Evan Y. ;
Li, Shi ;
Kadel, Edward E., III ;
Boyd, Zachary ;
Bourgon, Richard ;
Hegde, Priti S. ;
Mariathasan, Sanjeev ;
Thastrom, AnnChristine ;
Abidoye, Oyewale O. ;
Fine, Gregg D. ;
Bajorin, Dean F. .
LANCET, 2017, 389 (10064) :67-76
[4]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[5]   Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade [J].
Charoentong, Pornpimol ;
Finotello, Francesca ;
Angelova, Mihaela ;
Mayer, Clemens ;
Efremova, Mirjana ;
Rieder, Dietmar ;
Hackl, Hubert ;
Trajanoski, Zlatko .
CELL REPORTS, 2017, 18 (01) :248-262
[6]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[7]   Broadening horizons: the role of ferroptosis in cancer [J].
Chen, Xin ;
Kang, Rui ;
Kroemer, Guido ;
Tang, Daolin .
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (05) :280-296
[8]   Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy [J].
Davoli, Teresa ;
Uno, Hajime ;
Wooten, Eric C. ;
Elledge, Stephen J. .
SCIENCE, 2017, 355 (6322)
[9]   Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death [J].
Dixon, Scott J. ;
Lemberg, Kathryn M. ;
Lamprecht, Michael R. ;
Skouta, Rachid ;
Zaitsev, Eleina M. ;
Gleason, Caroline E. ;
Patel, Darpan N. ;
Bauer, Andras J. ;
Cantley, Alexandra M. ;
Yang, Wan Seok ;
Morrison, Barclay, III ;
Stockwell, Brent R. .
CELL, 2012, 149 (05) :1060-1072
[10]   Identification of Frataxin as a regulator of ferroptosis [J].
Du, Jing ;
Zhou, Yi ;
Li, Yanchun ;
Xia, Jun ;
Chen, Yongjian ;
Chen, Sufeng ;
Wang, Xin ;
Sun, Weidong ;
Wang, Tongtong ;
Ren, Xueying ;
Wang, Xu ;
An, Yihan ;
Lu, Kang ;
Hu, Wanye ;
Huang, Siyuan ;
Li, Jianghui ;
Tong, Xiangmin ;
Wang, Ying .
REDOX BIOLOGY, 2020, 32